MOREADITH RANDALL (Chief Scientific Officer) sold 39K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $97.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2026ACC: 0001301120-26-000016
Officer· Chief Scientific Officer
Since Feb 2026
-39K
Net shares
Net seller
$97.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
39K acquired · 78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+39K
Price / share
$0.06
Trade value
$2.34K
% of position
New position
3/19/2026
0.00→39K
Common Stock
Direct
Shares
−39K
Price / share
$2.50
Trade value
$97.50K
% of position
New position
3/19/2026
39K→0.00
Total
Net shares
+0.00
Net value
-$95.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/19/2026 | M · Option Exercise | +39K | $0.06 | $2.34K | New position | 0.00 | 39K |
| Common Stock Direct | 3/19/2026 | S · Sale | −39K | $2.50 | $97.50K | New position | 39K | 0.00 |
| Total | +0.00 | -$95.16K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
39K shares
Shares
−39K
Strike price
0.06
Held after
274.19K
Exercisable
—
3/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock39K shares | 3/19/2026 | M · Option Exercise | −39K | 0.06 | — | 274.19K |